Concepedia

Maura Crowley

MC

Statistics

Publications

11

Citations

1.5K

H-Index

11

Active since

2001

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Harvard University

Novartis Institutes for BioMedical Research

Novartis (China)

Maura Crowley is an author at Novartis (Switzerland) specializing in medicine, complement system, and immunology.

Publications per year

2001–2022

11

Publications

11

Migratory Properties of Naive, Effector, and Memory Cd8+ T Cells

Wolfgang Weninger, Maura Crowley, N. Manjunath et al. · The Journal of Experimental Medicine · 2001 · 517 citations · Full text

, , +17

Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes

N. Manjunath, Premlata Shankar, Junmei Wan et al. · Journal of Clinical Investigation · 2001 · 404 citations · Full text

, , +17

Small-molecule factor B inhibitor for the treatment of complement-mediated diseases

Anna Schubart, Karen Anderson, Nello Mainolfi et al. · Proceedings of the National Academy of Sciences · 2019 · 216 citations · Full text

, , +17

Naive T Cell Recruitment to Nonlymphoid Tissues: A Role for Endothelium-Expressed CC Chemokine Ligand 21 in Autoimmune Disease and Lymphoid Neogenesis

Wolfgang Weninger, Hege S. Carlsen, Mahmoud Goodarzi et al. · The Journal of Immunology · 2003 · 190 citations

, , +17

Discovery of 4-((2 <i>S</i> ,4 <i>S</i> )-4-Ethoxy-1-((5-methoxy-7-methyl-1 <i>H</i> -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases

Nello Mainolfi, Takeru Ehara, Rajeshri G. Karki et al. · Journal of Medicinal Chemistry · 2020 · 60 citations

, , +17

1–5 of 11